Occupational Cancer Screening in Firefighters: A Pilot Study Within the Inova Health System
Part of paid clinical trials in Fairfax, Virginia.
- Sponsor
- Inova Health Care Services
- Study ID
- NCT06931561
- Status
- Recruiting
Conditions
- Cancer
Eligibility Criteria
- Sex
- ALL
- Age
- 35 Years - 85 Years
- Healthy Volunteers
- Not accepted
Interventions
- Whole Body MRI — PROCEDUREWhole body MRI
- Whole Body Ultrasound — PROCEDUREWhole Body Ultrasound
- MCD Assay — DEVICECancer detection blood test
- Occupational Exposure Questionnaire — OTHERQuestionnaire
Study Details
The purpose of this study is to further understand the clinical impact and follow-up steps that may be required based on using whole-body Magnetic Resonance Imaging (MRI) or whole-body ultrasound and blood tests to detect multiple cancers in firefighters. This study involves an investigational test (cancer blood test) that has not been approved by the U.S. Food and Drug Administration (FDA). Whole-body MRI and whole-body ultrasound are approved by the U.S. Food and Drug Administration (FDA) to be used in the diagnosis of some cancers and is approved for adults and children who present other signs of potential disease. In this study, however, the whole-body MRI and the whole-body ultrasound are considered investigational devices because they are not yet approved for use in healthy adults with no other cancer indications.
Key Dates
- Start date
- Feb 11, 2025
- Status verified
- Apr 2025
- Primary completion
- Sep 30, 2028
- Completion
- Sep 30, 2028
Study Design
- Enrollment
- 800 participants (estimated)
- Allocation
- RANDOMIZED
- Intervention model
- SINGLE_GROUP
- Primary purpose
- SCREENING
Arms
- Active Comparator: Whole Body MRIPrenuvo whole body magnetic resonance imaging
- Active Comparator: Whole Body UltrasoundHigh frequency sound waves
Primary Outcome Measure
Number of confirmed pre-malignancies detected with each investigational screening tool [ Time Frame: up to 1 year (± 2 months) ]
Central Contacts
- Salman Baig(571) 472-3500
- Bryan Bassig, PhD(571) 472-3500
Locations (1)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| Inova Schar Cancer - Saville Cancer Screening and Prevention Center | Fairfax | Virginia | 22031 | Rebecca Kaltman, MD (PRINCIPAL_INVESTIGATOR) Bryan Bassig, PhD (SUB_INVESTIGATOR) Jennifer Lund, DO (SUB_INVESTIGATOR) |
Find similar trials in Fairfax, VA
Related Studies
- SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and RegistryRecruiting · Massive Bio, Inc. · Birmingham, Alabama
- Pan Tumor Rollover StudyPHASE2 · Recruiting · Bristol-Myers Squibb · Huntsville, Alabama
- An Internet-based Program to Help Cancer Survivors Manage PainRecruiting · Wake Forest University Health Sciences · Fort Smith, Arkansas
- TTX-080 HLA-G Antagonist in Subjects With Advanced CancersPHASE1 · Recruiting · Tizona Therapeutics, Inc · Tucson, Arizona